🇺🇸 FDA
Patent

US 8110569

Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use

granted A61PA61P25/00

Quick answer

US patent 8110569 (Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use) held by The Regents of the University of California expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61P, A61P25/00